OQROGet OQRO Pro
Insider trade

Boston Scientific (BSX)Director bought ~$126K

David C Habiger, Director at Boston Scientific, bought ~$126K of Boston Scientific shares.

~$126K
Approx. value · 2,250 sh @ $55.92
14K
Holds after · shares reported
Traded
May 20, 2026
Filed
May 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 4, 2025Federal contract · $601K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $601K obligated to date
  2. Dec 23, 2025Federal contract · $493K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $493K obligated to date
  3. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  4. Mar 27, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  5. Apr 22, 2026Company filing · Form 8-K · ResultsReported its results
  6. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  7. Apr 30, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
  8. May 6, 20265% stakeFMR LLC reported a passive stake (13G) of 5.1%
  9. May 11, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  10. May 19, 2026Insider · First insider buy since Dec 2024Director purchased ~$125K of BSX shares in the open market
  11. May 19, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  12. May 20, 2026 · this disclosureInsider · 3 insiders in a week, 6th time since 2006Director purchased ~$126K of BSX shares in the open market

What came next

  1. May 20, 2026Insider · 2 peopleInsiders: 2 purchases (~$303K)
  2. May 29, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  3. Jun 4, 2026CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  4. Jun 5, 2026Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  5. Jul 14, 2026FDARecall: Suture Cinch Long 1pk. Endoscopic tissue approximation device.
  6. Jul 16, 2026Federal contract · $608K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $608K obligated to date
  7. Jul 21, 2026Company filing · Form 8-K · RestructuringAnnounced job cuts, closures or a restructuring“On July 21, 2026, the Board of Directors of Boston Scientific Corporation (the “Company”) approved a new global restructuring program (the “2026 Restructuring Plan”).”
  8. Jul 22, 2026FDARecall: Boston Scientific Corporation StoneSmart Connect Console Contents: (1) Power Cord, (1) Power Adaptor, (1)DVI Cable, (1) DVI to HDMI Cable, (1) DisplayPort Cabl…
  9. Jul 24, 2026FDAFDA device clearance: TheraSphere 360™ Y-90 Management Platform
  10. Jul 24, 2026FDAFDA device clearance: OBSIDIO Conformable Embolic
  11. Jul 24, 2026FDAFDA device clearance: FARADRIVE™ Steerable Sheath (M004PF21M402)
  12. Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
  13. Jul 31, 2026InsiderDirector purchased ~$227K of BSX shares in the open market
  14. Aug 3, 2026Insider · 2 peopleInsiders: 2 purchases (~$9.1M)
  15. Aug 4, 2026FDAFDA device clearance: Navigator™ Flex Ureteral Access Sheath Set
  16. Aug 4, 2026Insider · 3 insiders in a week, 7th time since 2006Director purchased ~$6.8K of BSX shares in the open market
  17. Aug 5, 2026Insider · 3 insiders in a week, 7th time since 2006Director purchased ~$100K of BSX shares in the open market
  18. Aug 6, 2026FDARecall: LUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS US, Model Number 7260, All Versions (Current 7.8)
  19. Aug 6, 2026FDARecall: LUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS ANZ, Model Number 7248, All Versions (Current 7.7)
  20. Aug 6, 2026FDARecall: LUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS EU, Model Number 7246, All Versions (Current 7.7)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports, 64 fund holdings reports (13F) and 8 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by David C Habiger, Director

The full history of David C Habiger, Director is on the profile page.

How this filing works

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data